SAN DIEGO – Medtrade exhibitor Resmed recently launched the Sleep Institute, a global clinical insights initiative dedicated to advancing the science and understanding of sleep health.

Sleep Institute partners with clinicians, researchers, policymakers, and health system leaders to deliver objective, non-commercial, evidence-based insights that help inform care innovation, support policy decisions, and elevate sleep as a global health priority. The announcement comes ahead of the World Sleep Congress, taking place September 5–10 in Singapore.

Sleep disorders are among the most common health challenges worldwide, with an estimated 1 billion people living with obstructive sleep apnea (OSA) and about 852 million adults experiencing clinically relevant insomnia. Yet, the majority of people remain undiagnosed, fueling higher rates of chronic disease, lost productivity, and rising healthcare costs. To help address this gap, Sleep Institute publishes original research, expert perspectives, and real-world data to support earlier and more accurate diagnosis and guide more informed clinical, policy, and system-level strategies.

“Sleep Institute reflects Resmed’s commitment to advancing sleep health worldwide,” said Kimberly L. Sterling, vice president, Health Research at Resmed, on behalf of Sleep Institute. “It’s about moving from awareness to action — giving global health and policy leaders the insights they need to close today’s care gaps and shape tomorrow’s sleep medicine.”